Belgian lab sues Dutch state for ‘support’ SIP-test
The Belgian laboratory Gendia, a major maker of Non-Invasive Prenatal Testing (SIP), suing the Dutch state for unlawful state aid.
Gendia earned over the past years, to Dutch women who, in their own country were not eligible for the blood test, which, inter alia, Down’s syndrome brings to light. But because the government is now eight university medical centers (UMC’s) with 26 million euros per year goes to subsidize so that the test is relatively cheap to offer, threatening the company from the Dutch market to be priced.
The Belgian lab has the number of evaluations performed significantly decline. “Normally we sit on 100 to 120 customers per week through our two hundred priklocaties in the Netherlands, last month, there were still only 45,” says Patrick Willems from Gendia to the Volkskrant.
From april 1, is SIP available for all pregnant women. Yet there were only women in whom the blood test an increased risk of Down came the blood test.
The own contribution amounts to 175 euro. Gendia is not entitled to the subsidy scheme and therefore that there is distortion of competition. The company hopes through a short case for each other to get that the scheme is suspended, so that then the European Commission an opinion on can sheets.
Dutch women did not have to go to Belgium for the SIP. Gendia has two hundred places in the Netherlands ‘priklocaties’. The lab says more than 21,000 women to have helped.
Hospitals let it know a rush is expected. The three academic centers, the NARROWLY offering (Rotterdam Erasmus MC, VUmc in Amsterdam and Maastricht UMC+) count from Monday to thirty times as many tests to take.
They do now share, like, ten tests per day, but anticipate to 360 tests per day. To do this, more and more people adopted and is more laboratory equipment purchased.